John W. Rose
( out of 171 reviews )

John W. Rose, MD

Languages spoken: English

Clinical Locations

Imaging & Neurosciences Center

Salt Lake City
801-585-7575
Directions

  • John Rose, MD, is Neuroimmunology & Autoimmune Neurology Division Chief and Professor of Neurology at the University of Utah, and is chief of neurology at the Salt Lake City Veterans Administration Hospital. Dr. Rose and his colleagues investigate diverse aspects of multiple sclerosis (MS), including the immunopathology of MS and related models, the development of new treatments for MS, early disease detection with advanced magnetic resonance imaging, and the detection of susceptibility genes for MS.

    Dr. Rose's focus is on multiple sclerosis clinical care and research. His clinic is a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center. There are ongoing clinical investigations of neurogenic pain, OCT, and immunotherapies. One special area of research is Pediatric Multiple Sclerosis, including clinical and translational investigations. Another important area is development of Magnetic Resonance Imaging for detection of demyelination and remyelination.

    Dr. Rose sees patients at University of Utah, a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center.

    His favorite sport is lacrosse.

    Specialties

    Board Certification

    American Board of Psychiatry & Neurology (Neurology)
    National Board of Medical Examiners

    Patient Rating

    5.0 /5
    ( out of 171 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    March 26, 2025
    CLINICAL NEUROSCIENCES CENTER

    Dr. Rose is an excellent neurologist and MS specialist. I have trusted him for care since being diagnosed in 2000.

    March 21, 2025
    CLINICAL NEUROSCIENCES CENTER

    He's the BEST!

    March 19, 2025
    CLINICAL NEUROSCIENCES CENTER

    I've been living with MS for 33 years now and Dr. Rose is the best MS Specialist/neurologist I've ever had. I can't thank Dr. Rose enough for his expert care. He's thorough, compassionate, and always ready to listen. His ability to explain complex medical terms in simple, understandable language is a blessing. I trust him completely with my health care. He has provided me with a wealth of information and guidance on Multiple Sclerosis and other health care issues. Dr. Rose is an amazing doctor who is truly invested in his patients' health. His enthusiasm for his work is apparent. He has provided me with a wealth of information and guidance on Multiple Sclerosis. His explanations are always clear and concise. He takes the time to listen to my concerns and works together with me to come up with the best course of action. Thank you for everything Dr. Rose. You are the best!!!

    March 18, 2025
    CLINICAL NEUROSCIENCES CENTER

    I liked that he was talking about treatment at my first visit. Obviously a few more tests need to been done but he seems like making me feel better is his #1 priority.

    February 27, 2025
    CLINICAL NEUROSCIENCES CENTER

    I've been going to Dr Rose for over 20 years!! I love that man! He's such a good doctor!

    February 06, 2025
    CLINICAL NEUROSCIENCES CENTER

    He's Great! He helped me get a new prescription for Rebif

    January 17, 2025
    CLINICAL NEUROSCIENCES CENTER

    Dr. Rose is the best!

    January 09, 2025
    CLINICAL NEUROSCIENCES CENTER

    Dr. Rose and His team are very Knowledgeable innovative patient gentle kind and caring toward his patients!!

    December 11, 2024
    IMAGING AND NEUROSCIENCES CENTER

    Dr. Rose has always treated me with courtesy and respect. I feel that I have received the best care for my diagnosis. There is NO DOUBT that he is the best Dr. in his field. I have been seeing him for almost 30 years, and have been extremely happy with his care!!

  • John Rose, MD, is Neuroimmunology & Autoimmune Neurology Division Chief and Professor of Neurology at the University of Utah, and is chief of neurology at the Salt Lake City Veterans Administration Hospital. Dr. Rose and his colleagues investigate diverse aspects of multiple sclerosis (MS), including the immunopathology of MS and related models, the development of new treatments for MS, early disease detection with advanced magnetic resonance imaging, and the detection of susceptibility genes for MS.

    Dr. Rose's focus is on multiple sclerosis clinical care and research. His clinic is a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center. There are ongoing clinical investigations of neurogenic pain, OCT, and immunotherapies. One special area of research is Pediatric Multiple Sclerosis, including clinical and translational investigations. Another important area is development of Magnetic Resonance Imaging for detection of demyelination and remyelination.

    Dr. Rose sees patients at University of Utah, a Partner in Care with the National Multiple Sclerosis Society and designated a Comprehensive Care Center.

    His favorite sport is lacrosse.

    Board Certification and Academic Information

    Academic Departments Neurology -Professor
    Board Certification
    American Board of Psychiatry & Neurology (Neurology)
    National Board of Medical Examiners

    Education history

    Fellowship Neuroimmunology (July 1981 to June 1985) - National Institute of Health Fellow
    Fellowship Neurology (July 1979 to June 1980) - National Institute of Health Fellow
    Chief Resident Neurology (July 1978 to June 1978) - University of Maryland Chief Resident
    Residency Neurology (July 1976 to June 1979) - University of Maryland Resident
    Internship Medicine (July 1975 to June 1976) - Maryland General Hospital Intern
    Professional Medical Medicine (September 1971 to June 1975) - University of Maryland M.D.
    Undergraduate Biology (September 1969 to June 1971) - Johns Hopkins University B.A.

    Selected Publications

    Journal Article

    1. Gambrah-Lyles C, Varun Kannan 2, Tim Lotze 2, Aaron Abrams 3, Teri Schreiner 4, Moses Rodriguez 5, T Charles Casper 6, John W Rose 7, Mark P Gorman 8, Tanuja Chitnis 9, Sara Loud 10, Yolanda Wheeler 11, Soe Mar 12 US Network of Pediatric MS Centers (2024). Assessing the Needs and perceptions in research participation pediatric onset multiple sclerosis; a multi-stakeholder survey. Pediatr Neurol. 2024 Feb:151:115 120. doi:10.1016/j.pediatrneurol.2023.11.019.Epub 2023 Dec 4. PMID: 38154238.
    2. Nasr Z, Virupakshaiah A, Schoeps VA, Cherbuin N, Casper TC, Waltz M, Hart J, Rodriguez M, Gorman MP, Benson LA, Chitnis T, Rensel M, Abrams A, Krupp L, Waldman AT, Lotze T, Aaen GS, Mar S, Schreiner T, Wheeler Y, Rose J, Shukla NM, Barcellos LF, Lucas R, Waubant E (2023). Gene-environment interactions and risk of pediatric-onset multiple sclerosis associated with time spent outdoors. Mult Scler Relat Disord, 82, 105351. (Read full article)
    3. Schoeps VA, Zhou X, Horton MK, Zhu F, McCauley KE, Nasr Z, Virupakshaiah A, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Banwell BL, Bar-Or A, Marrie RA, van Domselaar G, OMahony J, Mirza AI, Bernstein CN, Yeh EA, Casper TC, Lynch SV, Tremlett H, Baranzini S, Waubant E (2024). US Network of Pediatric MS Centers. Short-chain fatty acid producers in the gut are associated with pediatric multiple sclerosis onset. Ann Clin Transl Neurol. 2024 Jan;11(1):169-184. doi: 10.1002/acn3.51944. Epub 2023 Nov 13.PMID: 37955284.
    4. Malani Shukla N, Casper TC, Ness J, Wheeler Y, Chitnis T, Lotze T, Gorman M, Benson L, Weinstock-Guttmann B, Aaen G, Rodriguez M, Tillema JM, Krupp L, Schreiner T, Mar S, Goyal M, Rensel M, Abrams A, Rose J, Waltz M, Liu T, Manlius C, Waubant E (2023). U.S. Network of Pediatric Multiple Sclerosis Centers. Pediatr Neurol. 2023 Aug;145:125-131. doi: 10.1016/j.pediatrneurol.2023.04.020. Epub 2023 Apr 28.PMID: 37348193.
    5. Nasr Z, Schoeps VA, Ziaei A, Virupakshaiah A, Adams C, Casper TC, Waltz M, Rose J, Rodriguez M, Tillema JM, Chitnis T, Graves JS, Benson L, Rensel M, Krupp L, Waldman AT, Weinstock-Guttman B, Lotze T, Greenberg B, Aaen G, Mar S, Schreiner T, Hart J, Simpson-Yap S, Mesaros C, Barcellos LF, Waubant E (2023). Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. J Neurol Neurosurg Psychiatry, 94(7), 518-525. (Read full article)
    6. Hoshina Y, Wong KH, Galli J, Bacharach R, Klein J, Lebiedz-Odrobina D, Rose JW, Trump B, Hull C, Greenlee JE, Clardy SL (2023). Neurologic involvement in seronegative primary Sjögren's syndrome with positive minor salivary gland biopsy: a single-center experience. Front Neurol, 14, 1174116. (Read full article)
    7. Horton MK, Shim JE, Wallace A, Graves JS, Aaen G, Greenberg B, Mar S, Wheeler Y, Weinstock-Guttman B, Waldman A, Schreiner T, Rodriguez M, Tillema JM, Chitnis T, Krupp L, Casper TC, Rensel M, Hart J, Quach HL, Quach DL, Schaefer C, Waubant E, Barcellos LF (2023). Rare and low-frequency coding genetic variants contribute to pediatric-onset multiple sclerosis. Mult Scler. 2023 Apr;29(4-5):505-511. doi: 10.1177/13524585221150736. Epub 2023 Feb 8.PMID: 36755464.
    8. Gholizadeh S, Exuzides A, Lewis KE, Palmer C, Waltz M, Rose JW, Jolley AM, Behne JM, Behne MK, Blaschke TF, Smith TJ, Sinnott J, Cook LJ, Yeaman MR, Guthy-Jackson Charitable Foundation CIRCLES Study Group (2022). Clinical and epidemiological correlates of treatment change in patients with NMOSD: insights from the CIRCLES cohort. J Neurol, 270(4), 2048-2058. (Read full article)
    9. Schreiner T, Wilson-Murphy M, Mendelt-Tillema J, Waltz M, Codden R, Benson L, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Roalstad S, Rodriguez M, Rose J, Shukla N, Waubant E, Wheeler Y, Casper TC, Chitnis T (2023). Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2. Mult Scler. 2023 Apr;29(4-5):576-584. doi: 10.1177/13524585231151948. Epub 2023 Mar 23.PMID: 36960480.
    10. Pizzolato Umeton R, Waltz M, Aaen GS, Benson L, Gorman M, Goyal M, Graves JS, Harris Y, Krupp L, Lotze TE, Shukla NM, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Roalstad S, Rodriguez M, Rose J, Waubant E, Weinstock-Guttman B, Casper C, Chitnis T, US Network of Pediatric MS Centers (2022). Therapeutic Response in Pediatric Neuromyelitis Optica Spectrum Disorder. Neurology, 100(9), e985-e994. (Read full article)
    11. Ziaei A, Lavery AM, Shao XM, Adams C, Casper TC, Rose J, Candee M, Weinstock-Guttman B, Aaen G, Harris Y, Graves J, Benson L, Gorman M, Rensel M, Mar S, Lotze T, Greenberg B, Chitnis T, Hart J, Waldman AT, Barcellos LF, Waubant E (2022). Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Mult Scler, 28(9), 13524585211069926. (Read full article)
    12. Williams JP, Abbatemarco JR, Galli JJ, Rodenbeck SJ, Peterson LK, Haven TR, Street M, Rose JW, Greenlee JE, Soldan MMP, Clardy SL (2021). Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay. Mult Scler Int, 2021, 8692328. (Read full article)
    13. Mandel LA, ODonnell E, Canenguez K, Castro-Mendoza PB, Lotze T, Waubant E, Weinstock-Guttmann B, Chitnis T (2021). Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis. Enhancing Equity.
    14. Mandel LA, ODonnell E, Canenguez K, Castro-Mendoza PB, Lotze T, Waubant E, Weinstock-Guttmann B, Chitnis T (2021). Family Perspectives on Clinical Research for Pediatric Multiple Sclerosis: Enhancing Equity. J Patient Exp, 8, 23743735211039319. (Read full article)
    15. Santoro JD, Kerr LM, Codden R, Casper TC, Greenberg BM, Waubant E, Kong SW, Mandl KD, Gorman MP (2021). Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome. Neurol Neuroimmunol Neuroinflamm, 8(6). (Read full article)
    16. Gaudioso C, Oo S, Mar S, Hendricks-Ferguson VL, Newland P, Varni JW (2021). PedsQL Multiple Sclerosis Module Domain and Item Development: Qualitative Methods. J Child Neurol, 36(10), 901-910. (Read full article)
    17. Abbatemarco JR, Galli JR, Sweeney ML, Carlson NG, Samara VC, Davis H, Rodenbeck S, Wong KH, Paz Soldan MM, Greenlee JE, Rose JW, Delic A, Clardy SL (2021). Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population. Neurol Neuroimmunol Neuroinflamm, 8(6). (Read full article)
    18. Greenberg BM, Casper TC, Mar SS, Ness JM, Plumb P, Liang S, Goyal M, Weinstock-Guttman B, Rodriguez M, Aaen GS, Belman A, Barcellos LF, Rose JW, Gorman MP, Benson LA, Candee M, Chitnis T, Harris YC, Kahn IL, Roalstad S, Hart J, Lotze TE, Rensel M, Rubin JP, Schreiner TL, Tillema JM, Waldman AT, Krupp L, Graves J, Drake K, Waubant E (2021). Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm, 8(5). (Read full article)
    19. Villani LA, Stulberg EL, Abbatemarco JR, Davidson CJ, Kadish R, Renner DR, Soldan MMP, Rose JW, Clardy SL, Greenlee JE (2021). Biopsy-proven PML in an HIV-negative patient with discoid lupus: Failure to detect JC virus in CSF. Clin Neurol Neurosurg, 209, 106843. (Read full article)
    20. Burt RK, Balabanov R, Han X, Quigley K, Arnautovic I, Helenowski I, Rose J, Siddique T (2020). Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial. Neurology, 96(6), e817-e830. (Read full article)
    21. Jeong K, Shah LM, Lee YJ, Thapa B, Sapkota N, Bisson E, Carlson NG, Jeong EK, Rose JW (2021). High-b diffusivity of MS lesions in cervical spinal cord using ultrahigh-b DWI (UHb-DWI). Neuroimage Clin, 30, 102610. (Read full article)
    22. Chan A, Rose J, Alvarez E, Bar-Or A, Butzkueven H, Fox RJ, Gold R, Gudesblatt M, Haartsen J, Spelman T, Wright K, Ferraro D, Sola P, Hodgkinson S, Kalincik T, Lechner-Scott J, McGuigan C, Spach K, Chen C, Fam S, Wu F, Miller C (2021). Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS. Neurol Clin Pract, 10(6), 510-519. (Read full article)
    23. Santoro JD, Waltz M, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rensel M, Rodriguez M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Hurtubise BF, Roalstad S, Rose J, Casper TC, Chitnis T, US Network of Pediatric MS Centers (2020). Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology, 95(13), e1844-e1853. (Read full article)
    24. Chitnis T, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Roalstad S, Rose J, Weiner HL, Casper TC, Rodriguez M, US Network of Paediatric Multiple Sclerosis Centers (2019). Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain, 143(9), 2733-2741. (Read full article)
    25. Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waltz M, Casper TC, Waubant E, US Network of Pediatric MS Centers (2020). Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol, 88(1), 42-55. (Read full article)
    26. Lord J, Paz Soldan MM, Galli J, Salzman KL, Kresser J, Bacharach R, DeWitt LD, Klein J, Rose J, Greenlee J, Clardy SL (2020). Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system. Neurol Neuroimmunol Neuroinflamm, 7(4). (Read full article)
    27. Wallach AI, Waltz M, Casper TC, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze TE, Mar S, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Charvet LE, Krupp LB (2019). Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Mult Scler, 26(14), 1938-1947. (Read full article)
    28. Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR, Guthy-Jackson Charitable Foundation International Clinical Consortium GJCFICC (2019). Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurol Neuroimmunol Neuroinflamm, 6(5), e583. (Read full article)
    29. Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee MS, Gorman M, Benson L, Mar S, Kahn I, Rose J, Casper TC, Quach H, Quach D, Schaefer C, Waubant E, Barcellos LF, US Network of Pediatric MS Centers (2019). miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Ann Clin Transl Neurol, 6(6), 1053-1061. (Read full article)
    30. Graves JS, Barcellos LF, Krupp L, Belman A, Shao X, Quach H, Hart J, Chitnis T, Weinstock-Guttman B, Aaen G, Benson L, Gorman M, Greenberg B, Lotze T, Soe M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Casper TC, Waubant E (2019). Vitamin D genes influence MS relapses in children. Mult Scler, 26(8), 894-901. (Read full article)
    31. Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, Tillema JM, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Belman A, Waubant E, Krupp L (2018). Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. J Child Neurol, 34(3), 148-152. (Read full article)
    32. Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos LF (2019). Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet, 15(1), e1007808. (Read full article)
    33. Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB (2019). Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial. JAMA, 321(2), 165-174. (Read full article)
    34. Thapa B, Sapkota N, Lee Y, Jeong K, Rose J, Shah LM, Bisson E, Jeong EK (2018). Ultra-high-b radial diffusion-weighted imaging (UHb-rDWI) of human cervical spinal cord. J Magn Reson Imaging, 49(1), 204-211. (Read full article)
    35. Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2017). Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler, 24(14), 1825-1834. (Read full article)
    36. Cohan S, Kappos L, Giovannoni G, Wiendl H, Selmaj K, Havrdov EK, Rose J, Greenberg S, Phillips G, Ma W, Wang P, Lima G, Sabatella G (2017). Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE. Mult Scler, 24(14), 1883-1891. (Read full article)
    37. Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E, US Network of Pediatric MS Centers (2018). Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology, 91(19), e1778-e1787. (Read full article)
    38. Mar S, Liang S, Waltz M, Casper TC, Goyal M, Greenberg B, Weinstock-Guttman B, Rodriguez M, Aaen G, Belman A, Barcellos LF, Rose J, Gorman M, Benson L, Candee M, Chitnis T, Harris Y, Kahn I, Roalsted S, Hart J, Lotze T, Moodley M, Ness J, Rensel M, Rubin J, Schreiner T, Tillema JM, Waldman A, Krupp L, Graves JS, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2018). Several household chemical exposures are associated with pediatric-onset multiple sclerosis. Ann Clin Transl Neurol, 5(12), 1513-1521. (Read full article)
    39. Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Charvet L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waldman AT (2018). Urban air quality and associations with pediatric multiple sclerosis. Ann Clin Transl Neurol, 5(10), 1146-1153. (Read full article)
    40. Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E, US Network of Pediatric MS Centers (2018). Heterogeneity in association of remote herpesvirus infections and pediatric MS. Ann Clin Transl Neurol, 5(10), 1222-1228. (Read full article)
    41. Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Kahn I, Rose J, Carmichael SL, Roalstad S, Waltz M, Casper TC, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2017). Dietary factors and pediatric multiple sclerosis: A case-control study. Mult Scler, 24(8), 1067-1076. (Read full article)
    42. Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Nourbakhsh B, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Casper TC, Waltz M, Graves JS, Network of Pediatric Multiple Sclerosis Centers (2018). Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Mult Scler Relat Disord, 22, 103-107. (Read full article)
    43. Katz Sand I, Fabian MT, Telford R, Kraus TA, Chehade M, Masilamani M, Moran T, Farrell C, Ebel S, Cook LJ, Rose J, Lublin FD (2018). Open-label, add-on trial of cetirizine for neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm, 5(2), e441. (Read full article)
    44. Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos LF, Lotze T, Carmichael SL, Roalstad S, Casper CT, Waubant E (2017). Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry, 89(1), 28-33. (Read full article)
    45. Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E, US Network of Pediatric MS Centers (2017). Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord, 18, 164-169. (Read full article)
    46. Baldassari LE, Rose JW (2017). Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis. Neurotherapeutics, 14(4), 842-858. (Read full article)
    47. Rose JW, Giovannoni G, Wiendl H, Gold R, Havrdov E, Kappos L, Selmaj KW, Zhao J, Riester K, Tsao LC, Greenberg SJ (2017). Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis. Mult Scler Relat Disord, 17, 32-40. (Read full article)
    48. Sapkota N, Shi X, Shah LM, Bisson EF, Rose JW, Jeong EK (2016). Two-dimensional single-shot diffusion-weighted stimulated EPI with reduced FOV for ultrahigh-b radial diffusion-weighted imaging of spinal cord. Magn Reson Med, 77(6), 2167-2173. (Read full article)
    49. Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Brnhielm M, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Metayer C, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2017). Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology, 88(17), 1623-1629. (Read full article)
    50. Bourne T, Waltz M, Casper TC, Kavak K, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Graves J, Greenberg B, Gorman M, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Olsen C, Roalstad S, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Kahn I, Waldman A, Barcellos L, Waubant E, Weinstock-Guttman B, US Network of Pediatric MS Centers (2017). Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population. J Neurol Sci, 375, 371-375. (Read full article)
    51. Graves JS, Chitnis T, Weinstock-Guttman B, Rubin J, Zelikovitch AS, Nourbakhsh B, Simmons T, Waltz M, Casper TC, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2017). Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis. Pediatrics, 139(4). (Read full article)
    52. Nourbakhsh B, Graves J, Casper TC, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos L, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2016). Dietary salt intake and time to relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry, 87(12), 1350-1353. (Read full article)
    53. Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Olsen C, Misra M, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Krupp L, Lotze T, Mar S, Ness J, Rose J, Rubin J, Schreiner T, Tillema J, Waldman A, Rodriguez M, Casper C, Waubant E, US Network of Pediatric MS Centers (2016). Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Ann Clin Transl Neurol, 3(12), 897-907. (Read full article)
    54. Sapkota N, Yoon S, Thapa B, Lee Y, Bisson EF, Bowman BM, Miller SC, Shah LM, Rose JW, Jeong EK (2016). Characterization of spinal cord white matter by suppressing signal from hindered space. A Monte Carlo simulation and an ex vivo ultrahigh-b diffusion-weighted imaging study. J Magn Reson, 272, 53-59. (Read full article)
    55. Graves JS, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E, US Network of Pediatric MS Centers (2016). Genetic predictors of relapse rate in pediatric MS. Mult Scler, 22(12), 1528-1535. (Read full article)
    56. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E, US Network of Pediatric MS Centers (2016). Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol, 16(1), 182. (Read full article)
    57. Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze T, Ness J, Rodriguez M, Tillema JM, Waubant E, Weinstock-Guttman B, Casper TC, US Network of Pediatric MS Centers (2016). Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics, 138(1). (Read full article)
    58. Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Centers (2016). Gut microbiota composition and relapse risk in pediatric MS: A pilot study. Apr 16(363), 153-157.
    59. McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J, Rodriquez M, Chitnis T, Mar S, Barcellos L, Laraia B, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant E (2016). A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord, 6(Mar 2016), 87-92.
    60. Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, Rodriguez M, Lotze T, Gorman M, Benson L, Belman A, Weinstock-Guttman B, Aaen G, Graves J, Patterson M, Rose JW, Casper TC (2015). Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology, 86(3), 245-52. (Read full article)
    61. Graves J, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E (2016). The US Network of Pediatric Multiple Sclerosis Centers: Genetic predictors of relapse rate in pediatric MS. Mult Scler, 1-8.
    62. Loughran-Fjeldstad AS, Carlson NG, Husebye CD, Cook LJ, Rose JW (2015). Retinal nerve fiber layer sector-specific compromise in relapsing and remitting multiple sclerosis. eNeurologicalSci, 1, 30-37. (Read full article)
    63. Kappos L, Wiendle H, Selmaj K, Arnold DL, Havrdova E, Boyko A, Kaufman M, Rose JW, Greenberg S, Sweetser M, Riester K, ONeill G, Elkins J (2015). Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med, 373(15), 1418-28.
    64. Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y, US Network of Pediatric Multiple Sclerosis Centers (2014). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol, 30(10), 1381-7. (Read full article)
    65. Carlson NG, Bellamkonda S, Schmidt L, Redd J, Huecksteadt T, Weber LM, Davis E, Wood B, Maruyama T, Rose JW (2015). The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death. J Neuroinflammation, 12, 101. (Read full article)
    66. Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, Simmons T, Casper TC, James J, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2014). Protective environmental factors for neuromyelitis optica. Neurology, 83(21), 1923-9. (Read full article)
    67. Charvet LE, ODonnell EH, Belman AL, Chitnis T, Ness JM, et al (2014). Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the "US Pediatric Multiple Sclerosis Network". Mult Scler, 20(11), 1502-10.
    68. Charvet LE, Cleary RE, Vazquez K, Belman AL, Krupp LB (2014). Social cognition in pediatric-onset multiple sclerosis (MS). Mult Scler, 20(11), 1478-84. (Read full article)
    69. Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y (2014). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol, 09/30/2014, 1-7.
    70. Sheridan JP, Robinson RR, Rose JW (2014). Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis. Expert Rev Clin Pharmacol, 7(1), 9-19.
    71. Chitnis T, Guttmann CR, Zaitsev A, Musallam A, Weinstock-Guttman B, Yeh A, Rodriguez M, Ness J, Gorman MP, Healy BC, Kuntz N, Chabas D, Strober JB, Waubant E, Krupp L, Pelletier D, Erickson B, Bergsland N, Zivadinov R, US Network of Pediatric MS Centers of Excellence (2013). Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study. BMC Neurol, 13, 173. (Read full article)
    72. Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I (2013). Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol, 183(5), 1390-1396. (Read full article)
    73. Seo HS, Kim SE, Rose JW, Hadley JR, Parker DL, Jeong EK (2013). Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla. J Magn Reson Imaging, 38(5), 1162-1168.
    74. Yonnet GJ, Fjeldstad AS, Carlson NG, Rose JW (2014). Advances in the management of neurogenic detrusor overactivity in multiple sclerosis. Int J MS Care, 15(2), 66-72. (Read full article)
    75. Carlson NG, Rose JW (2013). Vitamin D as a clinical biomarker in multiple sclerosis. Expert Opin Med Diagn, 7(3), 231-42.
    76. Martins TB, Rose JW, Gardiner GL, Kusukawa N, Husebye D, Hill HR (2013). Cell-based reporter gene assay for therapy-induced neutralizing antibodies to interferon-beta in multiple sclerosis. J Interferon Res, 33(2), 52-7.
    77. Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, Brown T, ODonnell E, Parrish J, Preston T, Zaccariello M, Belman A, Chitnis T, Gorman M, Ness J, Patterson M, Rodriguez M, Waubant E, Weinstock-Guttman B, Yeh A, Krupp LB, Network of Pediatric MS Centers of Excellence (2012). Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol, 28(1), 102-7. (Read full article)
    78. Fjeldstad AS, Carlson NG, Rose JW (2012). Optical coherence tomography as a biomarker in multiple sclerosis. Expert Opin Med Diagn, 6(6), 593-604. (Read full article)
    79. Rose JW (2012). Anti-CD25 immunotherapy: regulating the regulators. Sci Transl Med, 4(145), 145fs25. (Read full article)
    80. Merrill RP, Hadley JR, Minalga E, Kholmovski EG, Vijayakumar S, Kim SE, Quigley EP, Parker DL, Rose JW (2012). A 28-channel coil array for improved imaging of the optic nerve. Sci Transl Med, 41B(3), 73-84.
    81. Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, Gobel K, Bdeir K, Chatzigeorgiou A, Wong C, Bhatia S Kruhlak MJ, Rose JW, Burns JB, Hill KE, Qu H, Zhang Y, Lehrmann E, Becker KG, Wang Y, Simon DI, Nieswandt B, Lambris JD, Li X, Meuth SG, Kubes P, Chavakis T (2012). Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res, 110(9), 1202-10.
    82. Fjeldstad AS, McDaniel J, Witman MA, Ives SJ, Zhao J, Rose JW, Hannon J, Wray DW, Richardson RS (2011). Vascular function and multiple sclerosis. J Neurol, 258(11), 2036-42. (Read full article)
    83. Martins TB, Rose JW, Jaskowski TD, Wilson AR, Husebye D, Seraj HS, Hill HR (2011). Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay. Am J Clin Pathol, 136(5), 696-704.
    84. Waldman AT, Gorman MP, Rensel MR, Austin Te, Hertz DP, et al (2011). Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. J Child Neurol, 26(6), 675-82.
    85. Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg JR, James JA, US Pediatric MS Network (2011). Common viruses associated with lower pediatric multiple sclerosis risk. Neurology, 76(23), 1989-95. (Read full article)
    86. Waldman AT, Gorman MP, Rensel MR, Austin TE, Hertz DP, Kuntz NL, Network of Pediatric Multiple Sclerosis Centers of Excellence of National Multiple Sclerosis Society (2011). Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. J Child Neurol, 26(6), 675-82. (Read full article)
    87. Rose JW, Carlson NG (2011). Clinical biomarkers in multiple sclerosis. Expert Opin Med Diagn, 5(3), 213-26. (Read full article)
    88. Yeh EA, Waubant E, Krupp LB, Ness J, Chitnis T, Kuntz N, Ramanathan M, Belman A, Chabas D, Gorman MP, Rodriguez M, Rinker JR 2nd, Weinstock-Guttman B, National Network of Pediatric MS Centers of Excellence (2010). Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Arch Neurol, 68(4), 437-44. (Read full article)
    89. Zollinger LV, Kim TH, Hill K, Jeong EK, Rose JW (2011). Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis. J Magn Reson Imaging, 33(3), 557-64. (Read full article)
    90. Minalga E, Rose JW, Choi SE, Jeong EK, Kholmovski E, et al (2011). A 20-channel coil for improved magnetic resonance imaging of the optic nerve. Concepts Magn Reson Part B Magn Reson Eng, 25(39B(1)), 26-36.
    91. Carlson NG, Rojas MA, Redd JW, Tang P, Wood B, Hill KE, Rose JW (2010). Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death. J Neuroinflammation, 7, 25. (Read full article)
    92. Wynn D, Kaufman M, Montalban X, Vollmer T, Simon J, Elkins J, ONeill G, Neyer L, Sheridan J, Wang C, Fong A, Rose JW, CHOICE investigators (2010). Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Lancet Neurol, 9(4), 381-90. (Read full article)
    93. Kim TH, Zollinger L, Shi XF, Kim SE, Rose J, Patel AA, Jeong EK (2010). Quantification of diffusivities of the human cervical spinal cord using a 2D single-shot interleaved multisection inner volume diffusion-weighted echo-planar imaging technique. AJNR Am J Neuroradiol, 31(4), 682-7. (Read full article)
    94. Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinski J (2010). Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Mult Scler, Mar(3), 342-50.
    95. Chabas D, Ness J, Belman A, Yeh EA, Kuntz N, Gorman MP, Strober JB, De Kouchkovsky I, McCulloch C, Chitnis T, Rodriguez M, Weinstock-Guttman B, Krupp LB, Waubant E, US Network of Pediatric MS Centers of Excellence (2010). Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology, 74(5), 399-405. (Read full article)
    96. Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose JW (2009). Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. J Neuroimmunol, 217(1-2), 95-101. (Read full article)
    97. Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE (2009). Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation, 6, 31. (Read full article)
    98. Rojas MA, Carlson NG, Miller TL, Rose JW (2009). Long-term daclizumab therapy in relapsing-remitting multiple sclerosis. Ther Adv Neurol Disord, 2(5), 291-7. (Read full article)
    99. Rose JW, Foley JF, Carlson NG (2009). Monoclonal antibody treatments for multiple sclerosis. Curr Treat Options Neurol, 11(3), 211-20. (Read full article)
    100. Mehta LR, Rose JW (2009). Recurrent granuloma annulare during treatment with daclizumab. Mult Scler, 15(4), 527-8.
    101. Carlson NG, Rojas MA, Black JD, Redd JW, Hille J, Hill KE, Rose JW (2009). Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor. J Neuroinflammation, 6, 5. (Read full article)
    102. Wolinski JS, Sochat T, Weiss S, Ladkani D PROMiSe Trial Study Group J Rose site PI (2009). Glatiramer acetate treatment in PPMS: why males appear to respond favorably. J Neurol Sci, 15, 286-928.
    103. Kim T, Zollinger L, Shu X, Rose JW, Jeong E (2009). Diffusion tensor imaging of ex vivo cervical spinal cord specimens: the immediate and long term effects of fixation on diffusivity. Anat Rec, 292, 234-41.
    104. Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose JW, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Volterelli JC, Burns WH (2009). Autologous non-myeloablative heamtopoetic stem cell transplantation for relapsing and remitting multiple sclerosis. Lancet Neurol, 8, 244-53.
    105. Wolinsky JS (2003). The diagnosis of primary progressive multiple sclerosis. J Neurol Sci, 206(2), 145-52.

    Review

    1. Kuntz NL, Chabas D, Weinstock-Guttman B, Chitnis T, Yeh EA, Krupp L, Ness J, Rodriguez M, Waubant E, Network of US Pediatric Multiple Sclerosis Centers (2010). Treatment of multiple sclerosis in children and adolescents. [Review]. Expert Opin Pharmacother, 11(4), 505-20. (Read full article)
    2. Yeh EA, Chitnis T, Krupp L, Ness J, Chabas D, Kuntz N, Waubant E, US Network of Pediatric Multiple Sclerosis Centers of Excellence (2009). Pediatric multiple sclerosis. [Review]. Nat Rev Neurol, 5(11), 621-31. (Read full article)

    Book Chapter

    1. Jacobson S, Rose J, Flerlage M, Mingioli E, McFarlin D, McFarland F (1986). Measles virus-specific human cytotoxic T cells generated in bulk cultures: Analysis of measles virus antigenic specificity. In Mahy BWJ (Ed.), The Biology of Negative Strand Viruses. Elsevier Biomedical Press.

    Book Review

    1. Rose JW (1984). Neuroimmunology. [Review of the book ].

    Editorial

    1. Rose JW (2009). Multiple sclerosis: evidence of maternal effects and an increasing incidence in women. Neurology, 73(8), 578-9. (Read full article)
    2. Rose J (2009). Multiple Sclerosis: Evidence of Maternal Effects and an Increasing Incidence in Women. Neurology, 73(8), 578-9.

    Abstract

    1. Carlson NG, Schmidt L, Redd J, Bellamkonda S, Wood B, Weber LM, Paz Soldan MM, RoseJW (2015). Vulnerability of oligodendrocyte precursor cells to death is modulated by key prostaglandins [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
    2. Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Misra M, Olsen CS, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Lotze T, Ness J, Rodriquez M, Rose JW, Rubin J, Schreiner T, Mendelt-Tillema J, Casper TC, Waubant E (2015). Effect of obesity and puberty on risk and age at onset of pediatric MS [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
    3. Aaen GS, Waltz M, Casper T, Ness J, Gorman M, Makahani N, Vargas W, Waubant E, Chitnis T, Lotze T, Graves J, Benson L, Tillema MJ, Rodriguez M, Rose JW, Weinstock-Guttman B, Krupp L, Belman A (10/08/2015). Acquisition of early developmental milestones and need for special education services in paediatric-onset multiple sclerosis [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
    4. Nourbakhsh B, Graves J, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J-M, Hart J, Lee M, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Simmons T, Casper C, Rose JW, Barcellos L, Waubant E (2015). Association of dietary salt intake and relapse rate in pediatric multiple sclerosis [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
    5. Loughran-Fjeldstad AS, Carlson NG, Cook LJ, Rose JW (2015). Longitudinal reduction of total macular volume in relapsing and remitting multiple sclerosis: indicative of ongoing neurodegeneration [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
    6. Wiendl H, Havrdova E, RoseJW, Giovannoni G, Tsao LC, Zhao J, Pan Q, Elkins J, Greenberg SJ (2015). Daclizumab high-yield process (DAC HYP) vs. intramuscular interferon beta-1a in subgroups predictive of active disease: results from the DECIDE study [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
    7. Katz Sand I, Fabian M, Cook L, Telford R, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin F (2015). An open-label add-on trial of cetirizine for neuromyelitis optica: baseline data and preliminary results [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
    8. Arnold DL, Kappos L, Wiendl H, Selmaj K, Havrdova E, Boyko A, Kaufman M, Rose JW, Greenberg S, Amaravadi L, Riestger K, Elkins J (2015). Benefits on brain MRI lesion activity with Daclizumab HYP compared with intramuscular interferon beta- 1a are maintained through 144 weeks’ treatment: results from the DECIDE study [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
    9. Paz Soldan M, Schmidt L, Wood B, Rose JW, Carlson N (2015). Prostaglandin F2a Receptor Mediates Oligodendrocyte Precursor Injury/Death: Potential Rose in Multiple Sclerosis. Washington D.C [Abstract]. Neurology, 84(14 Supplement), P5.210.
    10. Selmaj K, Kappos L, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Riester K, Sweetser M, Elkins J (2015). Safety and Tolerability Results from the DECIDE Study: A Phase 3 Active-comparator Study of Daclizumab HYP in Relapsing-remitting Multiple Sclerosis. [Abstract]. Neurology, 84(14 Supplement), P7.230.
    11. Rose JW, Wiendl H, Arnold D, Kappos L, Havrdova E, Selmaj K, Boyko A, Kaufman M, Greenberg S, Sweetser M, Riester K, Elkins J (2015). Daclizumab HYP Reduced Brain MRI Lesion Activity Compared with Interferon Beta-1a: Results from the DECIDE Study [Abstract]. Neurology, 84(14 Supplement), P7.252.
    12. Seminatore B, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper C, Waubant E (2015). Fat, Fiber, and Pediatric MS [Abstract]. Neurology, 84(14 Supplement), S38.002.
    13. McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tilleman JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant E (2015). A Case-control Study of Dietary Salt Intake and Risk of Pediatric Multiple Sclerosis (MS). Washington D.C. [Abstract]. Neurology, 84(14 Supplement), S38.003.
    14. Kappos L, Selmaj K, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Sweetser M, Riester K, Elkins J (2015). Daclizumab HYP Versus Interferon Beta-1a in Relapsing-remitting Multiple Sclerosis: Primary Results of the DECIDE Study [Abstract]. Neurology, 84(14 Suppliment), S4.003.
    15. Wang V, Clardy T, Rose JW, Burns J, Carlson N, Greenlee J, Clardy S (2015). Neuromyelitis Optica in Veterans [Abstract]. Neurology, 84(14 Supplement), P1.104.
    16. Sand IK, Fabian M, Cook L, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin F (2015). An Open Label Add-on Trial of Cetirizine for Neuromyelitis Optica [Abstract]. Neurology, 84(14 Supplement), P4.003.
    17. Wiendl H, Havrdova E, Rose JW, Riester K, Tsao C, Greenberg S (2015). Daclizumab HYP Versus Interferon β-1a Across Patient Demographic and Disease Activity Subgroups in the DECIDE Phase 3 Study [Abstract]. Neurology, 84(14 Supplement), P4.007.
    18. Tremlett H, Fadrosh D, Lynch S, Hart J, Gravas J, Lulu S, Aaen G, Belman A, Benson L, Casper C, Chitnis T, Gorman M, Krupp L, Lotze T, Ness J, Roalstac S, Rodriquez M, Rose JW, Tillema JM, Weinstock-Guttman B, Waubant E (2015). Gut Microbiome in Early Pediatric Multiple Sclerosis: A Case-control Study [Abstract]. Neurology, 84(14 Supplement), P4.027.
    19. Carlson N, Rojas M, Redd J, Tang P, Wood B, Hill K, Rose JW (2009). Cyclooxygenase-2 expression in oligodendrocytes increases sensitiity to excitotoxic death [Abstract]. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Dusseldorf, Germany.
    20. Rose JW, Quigley E, Anderson J, Kim S, Jeong EK, Minalga E, Merrill R, Parker D, Hadley R (2009). Imaging of the optic nerve with improved radiofrequency toils for 3T MRI. [Abstract]. First International Conference on Inflammation and Retinal Disease: Complement Biology and Pathology, Knossos, Crete.
    21. Tumani H, Brettschneider J, Jakowski T, Abdul S, Husebye D, Seraj H, Hill H, Fire E, Spector L, Dotan N, Rose JW (2009). Anti-GAGA4 IgM assay may distinguish primary progressive multiple sclerosis from relapsing remitting multiple sclerosis patients. [Abstract]. ACTRIMS, Atlanta, Geogia.
    22. Merrill R, Hadley R, Minalga E, Parker D, Vijayakumar S, Choi SEK, Bell L, Rose JW (2009). An improved 28 channel array for optic nerve imaging [Abstract]. International Society for Magnetic Resonance Imaging.
    23. Kim T, Kim SE, Patel A, Zollinger L, Rose JW, Jeong EK (2009). Diffusion tensor imaging of human spinal cords in cervical myelopathy [Abstract]. International Society for Magnetic Resonance Imaging, Honolulu, Hawaii.
    24. Rose JW, Jaskowski T, Husebye D, Seraj H, Hill H, Carlson N (2008). Anti-thyroid antibodies identify a subgroup of multiple sclerosis patients. [Abstract]. ECTRIMS, Montreal, Canada.
    25. Carlson N, Rojas M, Black J-D, Redd J, Hill K, Rose JW (2008). Neuroprotection by EP1 prostanoid receptor antagonists is modulated by microglia [Abstract]. Society for Neuroscience, Washington, DC.
    26. Tsunoda I, Rose JW, Carlson N (2008). Treatment on an animal model for MS with resveratrol, a red wine component [Abstract]. International Society for Neuroimmunology, Dallas, Texas.
    27. Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose JW (2008). The role of COX-2 in experimental oligodendrocytes death and demyelination [Abstract]. International society for Neuroimmunology, Dallas, Texas.
    28. Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose JW (2008). A COX-2 inhibitor limits demyelination in a murine model of MS and protects oligodendrocytes from excitotoxic death in culture. [Abstract]. ECTRIMS, Montreal, Canada.
    29. Mehta L, Rose JW (2008). Recurrent granuloma annulare occurring during treatment with daclizumab [Abstract]. ECTRIMS, Montreal, Canada.
    30. Jaskowski T, Husebye D, Yarden J, Spector L, Fire E, Dotan N, Hill H, Rose JW (2008). Performance of an anti-GAGA4 IgM assay in distinguishing MS patients from control groups in a US cohort: a cross sectional retrospective study [Abstract]. ECTRIMS, Montreal, Canada.
    31. Tsunoda I, Carlson N, Rose JW (2008). Treatment with a red wine component, resveratrol, in a virus induced model for MS [Abstract]. ECTRIMS, Montreal, Canada.
    32. Hadley R, Merrill R, Minalga E, Parker D, Rose JW (2008). Improved radio frequency coils for 3T magnetic resonance imaging of the optic nerve [Abstract]. ECTRIMS, Monteral, Canada.
    33. Burt R, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Rose JW, Testori A, Muraro P, Storek J and Voltarelli J (2008). Autologous non myeloablative hematopoetic stem cell transplantation for relapsing multiple sclerosis [Abstract]. ECTRIMS, Montreal, Canada.

    Other

    1. Vikram Bhise a, Michael Waltz b, Charles Casper b, Gregory Aaen c, Leslie Benson d, Tanuja Chitnis e, Mark Gorman f, Manu Goyal g, Yolanda Wheeler h, Timothy Lotze i, Soe Mar j, Mary Rensel k, Aaron Abrams l, Moses Rodriguez m, John Rose n, Teri Schreiner o, Nikita Shukla p, Emmanuelle Waubant q, Bianca Weinstock-Guttman r, Jayne Ness s, Jan Mendelt-Tillema m (2023). Silent findings:  Examination of asymptomatic demyelination in a pediatric US cohort. MS&RD Volume 71.
    2. Sebastian P, Cherbuin N, Barcellos LF, Roalstad S, Casper C, Hart J, Aaen GS, Krupp L, Benson L, Gorman M, Candee M, Chitnis T, Goyal M, Greenberg B, Mar S, Rodriguez M, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Graves J, Waubant E, Lucas R, US Network of Pediatric Multiple Sclerosis Centers (2021). Association Between Time Spent Outdoors and Risk of Multiple Sclerosis. Neurology (98(3), pp. e267-e278). United States. (Read full article)
    3. Jeong KE, Lee SY, Yeom SK, Carlson N, Shah LM, Rose J, Jeong EK (2021). Ultrahigh-b diffusion-weighted imaging for quantitative evaluation of myelination in shiverer mouse spinal cord. Magn Reson Med (87(1), pp. 179-192). United States. (Read full article)
    4. Horton MK, McCauley K, Fadrosh D, Fujimura K, Graves J, Ness J, Wheeler Y, Gorman MP, Benson LA, Weinstock-Guttman B, Waldman A, Rodriguez M, Tillema JM, Krupp L, Belman A, Mar S, Rensel M, Chitnis T, Casper TC, Rose J, Hart J, Shao X, Tremlett H, Lynch SV, Barcellos LF, Waubant E, US Network of Pediatric MS Centers (2021). Gut microbiome is associated with multiple sclerosis activity in children. Ann Clin Transl Neurol (8(9), pp. 1867-1883). United States. (Read full article)
    5. Wingerchuk DM, Fujihara K, Palace J, Berthele A, Levy M, Kim HJ, Nakashima I, Oreja-Guevara C, Wang KC, Miller L, Shang S, Sabatella G, Yountz M, Pittock SJ, J Rose, S Clardy and MM Paz Soldan in PREVENT Study Group (2021). Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD. Ann Neurol (89(6), pp. 1088-1098). United States. (Read full article)